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BACKGROUND: The stigma of HIV-infection may pro-
foundly affect the lives of persons living with HIV/AIDS
(PLHA). However few studies have examined the associ-
ation of HIV stigma with multiple components of HIV
treatment and care.
OBJECTIVES: To estimate the association between HIV
stigma and: self-reported access to care, regular source
of HIV care, and antiretroviral therapy adherence; and to
test whether mental health mediates these associations.
DESIGN: Cross-sectional study.
PARTICIPANTS: 202 PLHA living in Los Angeles County
in 2007.
MEASUREMENTS: Participants completed an anony-
mous survey, assessing internalized HIV stigma (28-
items, alpha = 0.93), self-reported access to medical
care (six items, alpha = 0.75), regular source of HIV
care, and antiretroviral therapy (ART) adherence.
RESULTS: One-third of participants reported high
levels of stigma; 77% reported poor access to care;
42.5% reported suboptimal ART adherence; and 10.5%
reported no regular source of HIV care. In unadjusted
analysis, those reporting a high level of stigma were
more likely to report poor access to care (OR=4.97,
95% CI 2.54–9.72), regular source of HIV care (OR=
2.48, 95% CI 1.00–6.19), and ART adherence (OR=
2.45, 95% CI 1.23–4.91). In adjusted analyses, stigma
was significantly associated with poor access to care
(OR=4.42, 95% CI 1.88–10.37), but not regular source
of HIV care or ART adherence. Mental health mediated
the relationship between stigma and ART adherence,
but not poor access to care or regular source of HIV
care.
CONCLUSIONS: The association of stigma with self-
reported access to care and adherence suggests that
efforts to improve these components of HIV care will
require a better understanding of the possible effects of
stigma and it′s mediators.
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INTRODUCTION
Advances in HIV treatment over the past decade have trans-
formed HIV-infection from a fatal diagnosis into a manageable
chronic illness.
1,2 Despite these dramatic advances, the social
aspect of the illness–including the stigma of HIV–continues to
threaten the emotional, mental, and physical well-being of
persons living with HIV/AIDS (PLHA).
The concept of stigma is complex and is rooted in deviance
from the values and social norms of a community.
3 Theoretical
frameworks of stigma grounded in the sociological and anthro-
pologic literature conceptualize stigma as a social process and
have been applied to mental illness, epilepsy, and HIV/AIDS
among other diseases.
4,5 The process of stigma involves the
identification and labeling of human differences, linking
labeled persons to negative stereotypes, and categorization to
facilitate discrimination and unequal outcomes. Finally, the
access to power of a dominant group further perpetuates the
cycle of discrimination and social inequity.
5 In this conceptu-
alization, “internalized stigma” occurs as the individual inter-
nalizes cultural norms that label him/her as a member of a
deviant group, and assumes a “spoiled identity”.
3 Additionally,
“internalized stigma” parallels the concept of “perceived dis-
crimination” in social psychology,
6,7 which has also been
associated with important health outcomes, including delays
in pharmacy refills and medical care.
8
Few studies have examined the association of stigma with
multiple components of HIV care simultaneously: including
access to care, regular HIV care, and adherence to treatment.
Furthermore, the effect of internalized HIV stigma on these
outcomes has not been documented. Stigma may influence
these outcomes through several possible pathways. One
mechanism through which internalized stigma could affect
self-reported access to care and having a regular source of care
is through perceived discrimination. PLHA who experience
greater stigmatization might perceive more difficulty accessing
care because fear of rejection and discrimination (conse-
quences of stigma) may lead them to perceive the health care
setting as intolerant and inaccessible. The literature docu-
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1101menting an association between perceived stigmatizing atti-
tudes from a health care provider and poor access to medical
care
9,10 lends credence to this assertion. Alternatively, poor
mental health may confound or mediate the relationship
between stigma and HIV care. Previous studies have described
an association between stigma and depressive symptoms,
11,12
as well as an association between stigma and low levels of
antiretroviral therapy (ART) adherence.
11,13 Additional studies
suggest an association of mental health with access and
adherence to ART.
14,15 Therefore, PLHA experiencing high
levels of stigma may be more likely to perceive barriers to
accessing and adhering to treatment because of depression or
other mental illness. Mental illness symptoms may result
directly from internalized stigma (suggesting mediation) or
from other forces (suggesting confounding) and both relation-
ships have some support from the existing literature.
16,17 Our
study is among the first to formally test whether mental illness
mediates the association between internalized stigma and
access and adherence to HIV treatment. Another potential
confounder of the association between internalized stigma and
treatment is social disadvantage. The association between
social disadvantage and care initiation, access, and adherence
has been well documented,
8,18 and previous studies suggest
an association between social disadvantage and perceived
discrimination and stigma.
19,20
In the present study, we hypothesized that internalized HIV
stigma would be associated with three key components of HIV
treatment: 1) self-reported access to medical care, 2) having a
regular source of HIV care, and 3) self-reported ART medica-
tion adherence. We also tested a secondary hypothesis that
mental health may mediate the relationship between stigma
and one or more of these outcomes. We adapted the Andersen
behavioral model of health services use to guide our study.
This model describes the role of predisposing factors (e.g.
stigma, mental health, race), enabling factors (e.g. insurance
status), and clinical need characteristics (e.g. CD4 cell count),
on behavioral health outcomes (access to care, regular source
of HIV care, ART adherence).
21,22
METHODS
Participants and Data Collection
We collected data from a diverse convenience sample of 202
HIV-positive adults in Los Angeles County in 2007. Partici-
pants were recruited from five community organizations
providing outreach and social services to PLHA, as well as
two HIV clinical care sites. By recruiting at community
organizations and clinical sites, we were able to include both
individuals who readily access the health system and those
who may not. Eligible participants were 18 years of age or
older, HIV-positive, able to answer questions in English, and
capable of providing informed consent.
We recruited participants through research assistants sta-
tioned at the sites and organization staff also referred interested
participants. Eligible participants were invited to complete a
154-item anonymous self-administered questionnaire, with a
Flesh-Kincaid reading level of Grade 6.4 (Microsoft Word 2000,
Redmond, WA). Participants were paid a $20 honorarium.
Informed consent was obtained for all participants, and the
UCLA IRB approved the study.
Measure of Internalized HIV Stigma
We measured internalized HIV stigma with a 28-item scale
developed from previously published work by the authors.
12,23
Scale scores ranged from 0–100, with higher scores indicative
of greater stigma. Internal reliability consistency for the overall
measure was 0.93. Mean scores for the stigma subscales were
computed, and the overall scale score was calculated as an
average of the subscale scores. Because the distribution of
stigma scores associated with the outcomes was not linear and
suggested a threshold effect, we created a dichotomous
variable of high internalized stigma for this analysis, such that
participants who on average responded some of the time, most
of the time, or all of the time (mean scale score of 50 or greater)
were characterized as having high stigma.
Measure of Access to Care
We used a six-item access to care measure (alpha=0.75) derived
from the HIV Cost and Services Utilization Study (HCSUS);
24
these items are presented in Table 3.A l li t e m sh a daf i v e - p o i n t
response scale (strongly agree, somewhat agree, unsure, some-
whatdisagree,strongly disagree). We createda scalebysumming
scores from the six items, with a range of possible values from 5–
30. “Poor access to care” was defined as responding strongly to
somewhat disagree or unsure to the six access items on average
(corresponding toa score of18 orhigher). This measurehas been
associated with utilization of care.
24
Regular Source of HIV Care
Having a regular source of HIV care was assessed by the
question, “Do you currently have a regular place to go for your
HIVmedical care?”(Yes/No). Thisitemhas beenassociatedwith
time to initiation of ART,
25 and time to entry into medical care.
26
Measure of ART Adherence
Self-reported ART adherence was assessed using the item
“How often during the past week were you able to take your
antiretroviral medications exactly as your doctor or nurse told
you?” Response options included none of the time, a little of the
time, some of the time, most of the time, all of the time. In our
analysis, optimal adherence was defined as “all of the time”
and suboptimal adherence was all other response options.
This item has been shown to be predict HIV viral load and CD4
cell count at this cut point.
27
Measure of Mental Health
Mental health composite scores (MCS) were derived from the
Medical Outcomes Study Short Form (SF-12), and scores were
linearly transformed to T scores (mean = 50, SD=10; higher
scores representing better health).
28,29 The MCS scale ranged
from 1 – 100 and was divided into 10–point increments (i.e. 1 –
10, 11 – 20, etc.) for this analysis.
Other Independent Variables
Other independent variables in the analysis included predis-
posing factors: age, gender, race/ethnicity, education, primary
language, relationship status, sexual orientation, history of
1102 Sayles et al.: Stigma and HIV care JGIMintravenous drug use (IDU); enabling factors: income, health
insurance; and clinical need characteristics: years since HIV
diagnosis, CD4 cell count, currently on ART.
Data Analysis
We first examined the distributions of all independent and
dependent variables. We then examined the bivariate associa-
tions between the predisposing factor of high internalized
stigma and the health behavior outcomes. We constructed
three separate multiple logistic regression models to estimate
the adjusted association between each outcome variable and
high internalized stigma, controlling for predisposing, en-
abling, and clinical need characteristics.
As a secondary goal of the study, we examined whether
mental health mediated the relationship between stigma and
each outcome.
30 Specifically, first we examined the association
between stigma and MCS. Next, we examined the association
between MCS and each of the three outcome variables in
separate models. If these first two associations are significant,
then the possibility of a mediation relationship is heightened.
According to standard criteria for assessing mediation, next we
examined the association between stigma and the outcomes.
In the final step, we examined the extent to which the
association between stigma and the outcomes was attenuated
by adding MCS to the model. We conducted these mediation
analyses in bivariate models, followed by multivariate models.
We used multiple imputation by chained equations (MICE)
with five replications to impute missing values for two
variables: history of IDU (11 observations missing), and CD4
cell count (38 observations missing). Li-Raghunathan-Rubin
estimates were used for calculating standard errors.
31 All
analyses were conducted using STATA 10.0 (Stata Corp,
College Station, TX).
RESULTS
Sample Characteristics
Two hundred and two participants completed the survey, and
refusal rates ranged from 10% to 30% by site. Participant
characteristics are presented in Table 1. Fifty percent of the
sample was female, and the mean age was 43 years. Fifty-six
percent were African American, 28% were White, and 10%
were Latino/a. The mean MCS score was 40.1 in the sample,
with a standard deviation of 11.2.
Internalized HIV Stigma
Mean scores for each stigma item, subscales, and the overall
stigma scale are presented in Table 2. The mean score on the
overall stigma scale of 41 reflects that on average participants
endorsed items describing experiences or perceptions of stigma
slightly less frequently than “some of the time”(mean score of 50).
Access to Care, Regular Source of HIV Care,
and ART Adherence
Seventy-seven percent of participants reported poor access to
care on one or more of the items (Table 3). Approximately 10%
reported having no regular source of HIV care. Of the 142
participants currently taking ART, 42.5% reported suboptimal
adherence.
Association of Internalized Stigma with Access,
Regular Source of Care, and Adherence
In bivariate analyses, participants experiencing high internal-
ized stigma more frequently reported poor access to care, no
regular source of HIV care, and suboptimal ART adherence
(Table 4). Respondents diagnosed with HIV in the past five years
had significantly increased oddsof reporting high levels of stigma
compared with those diagnosed more than five years ago (OR=
2.49; 95% CI=1.25, 4.98). MCS was significantly related to high
levels of stigma (OR=12.95, 95% CI=6.14, 37.10), as well as poor
self-reported access, no regular source of HIV care, and subop-
timal ART adherence (Table 4). Internalized stigma was not
associated with any of the other independent variables.
In multivariable analysis, internalized stigma was strongly
associated with poor access to care (OR=4.42; 95% CI=1.88,
10.37) but not the other two outcomes (Table 5). Poor access to
care was also significantly associated with younger age (OR=
5.43; 95% CI=1.52, 19.43), a history of IDU (OR=3.19; 95%
CI=1.24, 8.20), and income below FPL (OR=2.50; 95%
CI=1.10, 5.68). Having no regular source of HIV care was
significantly associated with younger age (OR=7.39; 95%
Table 1. Predisposing, Enabling, and Clinical Need Characteristics
of Sample (N=202)
CHARACTERISTICS
Predisposing Factors
Age % (n) –
18–35 20.0 (40)
36–49 54.0 (109)
50+ 26.0 (53)
Gender % (n) –
Male 49.5 (100)
Female 49.0 (99)
Female transgender 1.5 (3)
Race % (n) –
African American 56.0 (112)
White 28.0 (56)
Latino/a 10.0 (20)
Other 6.0 (12)
Education % (n) –
No / Some high school 24.0 (48)
Graduated from high school 46.0 (92)
College 30.0 (60)
Primary language English % (n) 94.0 (191)
Married / In a committed relationship % (n) 27.2 (55)
Sexual orientation % (n) –
Heterosexual 69.3 (140)
Homosexual / Bisexual 30.7 (62)
History of intravenous drug use (IDU) % (n) 22.5 (43)
Mental health composite score
(mean + standard deviation)
40.1+11.2
Enabling factors
Income below FPL* % (n) 54.0 (109)
No health insurance % (n) 55.5 (111)
Clinical need characteristics
Years since HIV diagnosis % (n) –
0–5 yrs 22.2 (43)
6–10 yrs 26.3 (51)
>10 yrs 51.5 (100)
Current CD4 cell count < 200 (cells/ul) % (n) 15.8 (32)
Currently taking antiretroviral therapy % (n) 71.4 (142)
* FPL = federal poverty level for family of two , less than $1140 per month
1103 Sayles et al.: Stigma and HIV care JGIMCI=1.26, 43.42). Finally, increased odds of suboptimal ART
adherence were found among respondents with lower MCS
(OR=1.50; 95% CI=1.01, 2.25) and those who identified as
heterosexual (OR=2.92; 95% CI=1.07, 7.98). All four stigma
subscales were significantly associated with poor self-reported
access to care. None of the subscales were significantly
associated with regular source of care (latter data not shown).
Mental Health as Mediator of Relationships
of Stigma with Access to Care and Adherence
To examine mental health as a potential mediator of the
relationship between stigma and our outcomes of interest, we
tested the mediation model as presented in Fig. 1. As described
earlier, stigma was significantly associated with MCS, as well
as with the outcomes of self-reported access to care and
suboptimal ART adherence. MCS was also significantly asso-
ciated with these two outcomes, controlling for the covariates.
Therefore, the conditions for the mediation hypothesis were
met. When the MCS was added to the model predicting poor
self-reported access to care, high stigma remained significantly
associated with poor access (OR=5.14, 95% CI=2.39, 11.90
without MCS and OR=4.42, 95% CI=1.88, 10.37 with MCS).
When the MCS was added to the model predicting suboptimal
ARTadherence, we found that association between high stigma
and adherence was no longer statistically significant (OR=
3.15, 95% CI=1.35, 7.36 without MCS and OR=2.09; 95% CI=
0.81, 5.39 with MCS). The results in both models were similar
when observations with missing data were excluded from the
analysis.
DISCUSSION
In this diverse sample of PLHA in Los Angeles County,
approximately one-third of participants reported experiencing
high levels of internalized HIV stigma. We found that respon-
dents experiencing high levels of stigma had over four times
the odds of reporting poor access to care. Mental health
Table 2. Internalized Stigma Scale Items and Scores
Internal Stigma Scale items
* Mean (SD)
†
Subscale 1 = Stereotypes of HIV 48 (21)
1. HIV is different than other diseases like
cancer because people with HIV are judged
66 (29)
2. People assume I have done something bad to get HIV 53 (32)
3. Society looks down on people who have HIV 59 (28)
4. People think that if you have HIV then you got
what you deserve
43 (30)
5. People blame me for having HIV 43 (35)
6. People assume I slept around because I have HIV 54 (33)
7. People think that if you have HIV you do not deserve
to have children
50 (34)
8. People are afraid to let someone with HIV adopt
a child
57 (29)
9. People think I am a bad person because I have HIV 34 (32)
10. Medical providers assume people with HIV
sleep around
38 (31)
11. People lose their jobs because they have HIV 46 (26)
12. People think you can′t be a good parent if you
have HIV
42 (31)
Subscale 2 = HIV Disclosure Concerns 32 (27)
13. I am concerned if I go to the HIV clinic someone
I know might see me
28 (33)
14. I am concerned if I have physical changes from
the HIV medicines people will know I have HIV
33 (33)
15. I am concerned if I go to an AIDS organization
someone I know might see me
30 (34)
16. I am concerned people will find out I have HIV
by looking at my medical paperwork
32 (35)
17. I am concerned that if I am sick people I know
will find out about my HIV
38 (35)
Subscale 3 = Social Relationship Stigma 29 (24)
18. Nurses and doctors treat people who have
HIV as if they are contagious
30 (30)
19. Nurses and doctors dislike caring for
patients with HIV
28 (28)
20. I feel abandoned by family members
because I have HIV
24 (33)
21. People treat me as less than human
now that I have HIV
29 (31)
22. People avoid me because I have HIV 24 (30)
23. People I am close to are afraid they will
catch HIV from me
26 (32)
24. I feel like I am an outsider because I have HIV 41 (35)
Subscale 4 = Self-Acceptance 54 (25)
25. I feel ashamed to tell other people that I have HIV 45 (36)
26. I am comfortable telling everyone I know that
I have HIV
‡
61 (35)
27. My family is comfortable talking about my HIV
‡ 55 (33)
28. It is important for a person to keep HIV a secret
from co-workers
56 (33)
Overall Stigma Scale 41 (19)
* Responses to each item are on a 5-point categorical response scale
(none of the time, a little of the time, some of the time, most of the time, or
all of the time)
† Possible range 0-100 with higher scores indicate greater levels of
internalized stigma
‡ Response scale values reversed for scoring
Table 3. Frequency of HIV-Positive Persons Reporting Health
Behavior Outcomes of Poor Access to Care, No Regular Source of
HIV Care, and Suboptimal ART Adherence
Poor access to care items (n=202) Disagree
responses (%)*
1. I am able to get medical care whenever I need it 24.0
2. Places where I can get medical care are
very conveniently located
26.4
3. I have never gone without the medical care
I needed because it is too expensive
42.3
4. I have easy access to the medical specialists
that I need
22.4
5. It is easy for me to get medical care in
an emergency
40.3
6. If I need hospital care, I can get admitted
without any trouble
27.9
Overall: Reported poor access to 1 or more of
the above items
77.0
No regular source of HIV Care (n=202) No
Do you currently have a regular place to go
for your HIV medical care?
10.5
Suboptimal ART adherence (n=142) Less than all
the time
†
How often during the past week were you able
to take your antiretroviral medications exactly
as your doctor or nurse told you to?
42.5
* Poor access defined as strongly/somewhat disagree or unsure to the
items above
† Suboptimal ART adherence defined as taking antiretroviral therapy
none, a little, some, or most of the time (vs. all the time)
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ART adherence, suggesting that the relationship between
stigma and ART adherence is mediated by mental health.
Additional prospective longitudinal studies in larger samples
are needed to better understand possible mediators of the
associations between HIV stigma and access to care and ART
adherence. This may in turn help to guide interventions to
improve HIV care and health outcomes for PLHA.
Our findings demonstrate that in a diverse and underserved
sample of PLHA, poor self-reported access to medical care is
strongly associated with experiencing HIV stigma. It did not
appear that mental health or other predisposing, enabling, or
clinical need factors explained this association. Poor self-
reported access to care could also itself be a result of the
perceived discrimination and social inequities that are central
to the process of stigma. In this scenario, it is possible that an
omitted variable that reflects perceived discrimination and
social disadvantage may influence both experiences of stigma
and self-reported access to care.
Interestingly, we found that stigma was not strongly asso-
ciated with having a regular source of HIV care in our sample
after controlling for predisposing, enabling, and clinical need
characteristics. One explanation for this may be that stigma
has less of a role in an established patient-provider relation-
ship compared with other factors such as patient-provider
concordance by race or gender, satisfaction, communication,
and trust.
32,33 Alternatively, we may have failed to identify an
association because the percentage of the sample reporting no
regular source of HIV care was small (10.5%).
Our data suggest that HIV stigma may be associated with
suboptimal ART adherence, and this relationship may be
partially mediated by lower mental health status. Specifically,
lower MCS was associated with suboptimal adherence, and
when MCS was included in the mediation model, the associ-
ation with stigma was attenuated and no longer significant.
This is consistent with previously published studies that
demonstrate that stigma and depression influence ART adher-
ence.
11,15 However, the interrelationship and pathways be-
tween stigma and other factors known to be associated with
adherence such as social support,
34 self-efficacy,
35 and atti-
tudes toward medication
36 need to be further delineated in
future studies in order to identify targets for effective interven-
tion programs.
In our study, PLHA diagnosed within the last 5 years
reported higher levels of stigma than those living longer with
the disease, suggesting that stigma may attenuate over time.
Future longitudinal studies should examine how HIV stigma
changes over time and with disease progression, as many
PLHA may live decades with this chronic disease. This finding
also suggest that addressing internalized stigma and its
Table 4. Bivariate Associations of Predisposing, Enabling, and Clinical Need Characteristics with Health Behavior Outcomes of Poor Self-
Reported Access to Care, No Regular Source of HIV Care, and Suboptimal ART Adherence
Dependent variable (Reference group) Poor self-reported access to care
odds ratio (95% CI) (n=202)
No regular source of HIV care
odds ratio (95% CI) (n=202)
Suboptimal ART adherence odds
ratio (95% CI) (n=142)
Predisposing factors
High internalized stigma (no) –– –
Yes 4.97 (2.54–9.72) 2.48 (1.00–6.19) 2.45 (1.23–4.91)
Mental health status –– –
Mental health composite score
(10-point increase)
1.73 (1.31–2.29) 1.54 (1.03– 2.31) 1.53 (1.12–2.09)
Age –– –
18–35 4.87 (2.11–11.23) 4.82 (1.87–12.41) 2.72 (1.03–7.18)
36–49 0.46 (0.26–0.81) 0.59 (0.23–1.46) 0.63 (0.32–1.25)
50 and over 0.85 (0.46–1.60) 0.26 (0.06–1.17) 0.80 (0.39–1.64)
Gender (male) –– –
Female 0.76 (0.44–1.32) 1.11 (0.45–2.76) 1.66 (0.87–3.19)
Race / Ethnicity (white) –– –
African American 1.06 (0.61–1.86) 1.12 (0.45–2.80) 1.32 (0.69–2.53)
Latino/a 1.44 (0.56–3.68) 0.93 (0.20–4.36) 1.91 (0.66–5.58)
Other Race 0.92 (0.29–2.95) 0.76 (0.92–6.23) 0.92 (0.24–3.50)
Education (more than high school diploma) –– –
High school diploma 0.86 (0.50–1.50) 1.51 (0.65–4.00) 1.11 (0.60–2.06)
Less than high school 1.25 (0.65–2.40) 0.72 (0.23–2.24) 1.68 (0.77–3.65)
Sexual orientation (homosexual / bisexual) –– –
Heterosexual 0.74 (0.43–1.30) 1.63 (0.63–4.23) 2.35 (1.23–4.50)
History of IDU (no) –– –
Yes 2.94 (1.41–6.11) 2.40 (0.92–6.27) 1.72 (0.79–3.73)
Enabling Factors
Income (above FPL*) –– –
Below FPL 1.96 (1.12–3.43) 1.20 (0.48–2.99) 1.01 (0.49–2.08)
Insurance (yes) –– –
No 0.53 (0.30–0.92) 0.59 (0.24–1.46) 1.05 (0.55–1.98)
Clinical need characteristics
Yrs since HIV diagnosis (>5) –– –
Less than 5 yrs 2.58 (1.26–5.32) 2.49 (0.95–6.47) 0.87 (0.36–2.06)
CD4 count (above 200) –– –
Below 200 0.91 (0.43–1.94) 0.52 (0.11–2.36) 0.65 (0.26–1.61)
* FPL = federal poverty level for family of two, less than $1140/month income
1105 Sayles et al.: Stigma and HIV care JGIMpotential impact on HIV treatment may be particularly impor-
tant to incorporate into programs targeting recently diagnosed
PLHA.
There were several limitations to this study. First, as our
data were cross-sectional, causality between internalized HIV
stigma and our outcomes cannot be established. Also, poten-
tially important covariates such as social inequality, social
support, and self-efficacy were not observed in our models.
However, our study does provide valuable information about
the strong association between stigma and self-reported access
Table 5. Multivariable Associations of Internalized Stigma with Poor Access to Care, No Regular Source of HIV Care, and Suboptimal ART
Adherence
Dependent Variable (Reference group) Poor Self-Reported Access to
Care Odds ratio (95% CI) (n=202)
No Regular Source of HIV
Care Odds ratio (95% CI) (n=202)
Suboptimal ART Adherence
Odds ratio (95% CI) (n=142)
Predisposing Factors
High internalized stigma (no) –––
Yes 4.42 (1.88–10.37) 2.25 (0.69–7.32) 2.09 (0.81–5.39)
Mental health status –––
Mental Health Composite Score
(10-point increase)
1.22 (0.87–1.71) 1.16 (0.68–1.99) 1.50 (1.01–2.25)
Age (50+) –––
18–35 5.43 (1.52–19.43) 7.39 (1.26–43.42) 3.35 (0.90–12.45)
36–49 0.71 (0.30–1.68) 1.93 (0.36–10.41) 0.64 (0.23–1.75)
Gender (male) –––
Female 0.87 (0.38–1.99) 0.97 (0.29–3.21) 1.52 (0.61–3.81)
Race / Ethnicity (white) –––
African American 1.34 (0.54–3.30) 0.93 (0.25–3.48) 1.42 (0.51–3.98)
Latino/a 1.65 (0.45–6.08) 1.54 (0.22–10.79) 3.34 (0.72–15.58)
Other race 1.30 (0.23–7.21) 0.78 (0.06–9.73) 0.88 (0.13–6.11)
Education (more than high school) –––
High school diploma 1.01 (0.41–2.50) 1.28 (0.34–4.82) 1.21 (0.42–3.49)
Less than high school 1.47 (0.44– 4.93) 0.51 (0.08–3.41) 1.35 (0.35–5.20)
Sexual orientation (homosexual / bisexual) –––
Heterosexual 0.56 (0.23–1.36) 2.42 (0.67–8.78) 2.92 (1.07– 7.98)
History of IDU (no) –––
Yes 3.19 (1.24–8.20) 1.89 (0.56–6.36) 1.78 (0.66–4.84)
Enabling factors
Income (above FPL*) –––
Below FPL 2.50 (1.10–5.68) 1.27 (0.40–4.07) 0.96 (0.38–2.40)
Insurance (yes) –––
No 0.61 (0.29–1.30) 0 .89 (0.29–2.72) 1.50 (0.61–3.66)
Clinical need characteristics
Yrs since HIV diagnosis (>5) –––
Less than 5 yrs 1.15 (0.44–3.00) 1.98 (0.62–6.32) 0.36 (0.12–1.09)
CD4 count (above 200) –––
Below 200 0.64 (0.25–1.64) 0.42 (0.08–2.19) 0.78 (0.25–2.37)
* FPL = federal poverty level for family of two, less than $1140/month
*Mediation models control for age, gender, race/ethnicity, education, sexual orientation, history of
intravenous drug use, income, insurance status, years since diagnosis, and CD4 count. 
†Relationship expressed as OR (95 % CI). 
Independent variable:
(Predisposing Factor)
Internalized HIV stigma
Mediator:
(Predisposing Factor)
Mental health status
Dependent variable:
(Behavioral Health Outcomes)
• Self-reported access to care 
• ART adherence 
9.42 (4.79-24.83)
†
Poor access: 1.47 (1.07-2.01) 
Suboptimal adherence: 1.65 (1.12-2.43)
Without mediator
Poor access: 5.14 (2.39 -11.09)
Suboptimal adherence: 3.15 (1.35 - 7.36)
With mediator
Poor access: 4.42 (1.88-10.37) 
Suboptimal adherence: 2.09 (0.81-5.39) 
Figure 1. Mediation model to explore the role of mental health in mediating the associations between internalized HIV stigma and poor
access to care and suboptimal art adherence*.
1106 Sayles et al.: Stigma and HIV care JGIMto care and adherence, and directs future work to further
delineate these relationships. Second, our study sample may
be biased (ascertainment bias) toward people who have already
partially engaged in medical care or social services, and it may
underestimate the association between poor access and inter-
nalized stigma for the most vulnerable group of PLHA who do
not access care or HIV services at all. Finally, although we
successfully recruited a sample of diverse PLHA, non-English
speakers such as Latino/as and Asian Americans were
underrepresented in our sample.
Despite these limitations, our study provides important
information about the association between internalized HIV
stigma and self-reported access to medical care and ART
adherence. Prospective studies that include more objective
measures of access to care, such as utilization of subspecialty
care, HIV care, preventive care, and emergency/hospital care,
would help us to better understand the access needs of
underserved PLHA over the course of their disease. Prospective
studies could also help us to examine the directionality of the
association between stigma and access to care, as well as to
identify additional factors that may mediate or moderate this
relationship. Finally, such studies could enable us to examine
changes in stigma and its contribution to health care and
health outcomes throughout the disease trajectory.
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